| GERON CORP. (DEL.) DL-001 |
| USA |
| Gesundheit |
| US3741631036 / 902213 |
| GON (Frankfurt) / GERN (NASDAQ) |
| FRA:GON, ETR:GON, GON:GR, NASDAQ:GERN |
| - |
| https://www.geron.com/ |
|
Geron Corporation is a biopharmaceutical company d..
>Volltext.. |
| 696.39 Mio. EUR |
| 584.6 Mio. EUR |
| 157.54 Mio. EUR |
| -53.13 Mio. EUR |
| -68.71 Mio. EUR |
| -0.1 EUR |
| 215.82 Mio. EUR |
| 68.71 Mio. EUR |
| -114.17 Mio. EUR |
| 4.36 |
| 490.3% |
| 62.28% |
| - |
| - |
| - |
| - |
| GERON |
| 08.12.25 |
|
||||
|
||||
|
||||
|
||||
|